Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Score) up to date its FY 2022 earnings steering on Tuesday. The corporate offered earnings per share steering of $7.36-$7.36 for the interval. The corporate issued income steering of $47.38 billion-$48.39 billion, in comparison with the consensus income estimate of $50.33 billion.
Bayer Aktiengesellschaft Buying and selling Up 1.4 %
BAYRY inventory traded up $0.19 throughout mid-day buying and selling on Tuesday, reaching $13.71. 1,060,103 shares of the inventory traded palms, in comparison with its common quantity of 1,046,155. The corporate has a debt-to-equity ratio of 1.00, a fast ratio of 0.84 and a present ratio of 1.18. Bayer Aktiengesellschaft has a one 12 months low of $11.41 and a one 12 months excessive of $18.45. The inventory has a market capitalization of $53.88 billion, a PE ratio of 6.23, a PEG ratio of 1.16 and a beta of 1.13. The enterprise has a 50-day transferring common worth of $12.58 and a two-hundred day transferring common worth of $14.44.
Wall Avenue Analyst Weigh In
A number of equities analysts just lately commented on the inventory. Deutsche Financial institution Aktiengesellschaft elevated their worth goal on shares of Bayer Aktiengesellschaft from €75.00 ($75.00) to €79.00 ($79.00) and gave the corporate a purchase ranking in a analysis report on Tuesday, August sixteenth. Exane BNP Paribas raised shares of Bayer Aktiengesellschaft from a impartial ranking to an outperform ranking in a analysis be aware on Tuesday, August thirtieth. JPMorgan Chase & Co. lifted their worth goal on shares of Bayer Aktiengesellschaft from €75.00 ($75.00) to €80.00 ($80.00) and gave the corporate an chubby ranking in a analysis be aware on Wednesday, August thirty first. Lastly, Morgan Stanley raised their worth goal on Bayer Aktiengesellschaft from €80.00 ($80.00) to €81.00 ($81.00) in a report on Wednesday, October twenty sixth. One funding analyst has rated the inventory with a maintain ranking and 9 have assigned a purchase ranking to the corporate. Based on information from MarketBeat, Bayer Aktiengesellschaft at the moment has a consensus ranking of Average Purchase and a consensus worth goal of $85.20.
About Bayer Aktiengesellschaft
(Get Score)
Bayer Aktiengesellschaft, collectively its subsidiaries, operates as a life science firm worldwide. It operates via Prescribed drugs, Shopper Well being, and Crop Science segments. The Prescribed drugs section affords prescription merchandise primarily for cardiology and girls’s well being care; specialty therapeutics within the areas of oncology, hematology, and ophthalmology; and diagnostic imaging tools and distinction brokers, in addition to cell and gene remedy.
See Additionally
This immediate information alert was generated by narrative science know-how and monetary information from MarketBeat with a view to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial crew previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.
Earlier than you think about Bayer Aktiengesellschaft, you may wish to hear this.
MarketBeat retains monitor of Wall Avenue’s top-rated and greatest performing analysis analysts and the shares they advocate to their purchasers every day. MarketBeat has recognized the 5 shares that prime analysts are quietly whispering to their purchasers to purchase now earlier than the broader market catches on… and Bayer Aktiengesellschaft wasn’t on the record.
Whereas Bayer Aktiengesellschaft at the moment has a “Average Purchase” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.
View The 5 Shares Right here
